Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|June 26, 2026
Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center StudyEinav Koren, Adar Yaacov, Jamal Zidan, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 21, 2019
Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case reportPamela Schaffer, Ron Batash, Birgit Ertl-Wagner, et al.
Molecular and Clinical Oncology|July 28, 2020
Erratum: Goblet cell carcinoid of the appendix: Two case reports and a review of the literatureAlejandro Livoff, Noam Asna, Enrique Gallego-Colon, et al.
Cells|January 9, 2026
The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor ManagementAdar Yaacov, Roni Gillis, Jaber Salim, et al.
Current Medicinal Chemistry|January 10, 2019
Management of Peripheral Neuropathy Induced by ChemotherapyMaayan Fradkin, Ron Batash, Shiran Elmaleh, et al.
Molecular and Clinical Oncology|October 18, 2019
Goblet cell carcinoid of the appendix: Two case reports and a review of the literatureAlejandro Livoff, Noam Asna, Enrique Gallego-Colon, et al.
Anti-Cancer Drugs|November 5, 2013
The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patientsTamar Safra, Noam Asna, Anat Veizman, et al.
Cancers|October 29, 2025
Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Oncologic Patients-A New Promise? Preliminary ResultsRon Batash, Noam Asna, Sara HaJ Ali, et al.
Harefuah|January 25, 2022
[PRIMARY GASTRIC PLASMACYTOMA IN A BREAST CANCER MALE PATIENT]Noam Asna, Mark Shlapobersky, Moshe Schaffer, et al.
Clinical Lung Cancer|March 10, 2025
The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pembrolizumab/ Sacituzumab GovitecanLaila C Roisman, Shir Mann, Afifi Basel, et al.
Pageof 3